Drug Profile
Racemetirosine - Yamo Pharmaceuticals
Alternative Names: DL-alpha-Methyltyrosine; L1-79Latest Information Update: 22 Nov 2023
Price :
$50
*
At a glance
- Originator Yamo Pharmaceuticals
- Class Behavioural disorder therapies
- Mechanism of Action Tyrosine hydroxylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Autistic disorder